Halliburton announced it will buy fellow oil services giant Baker Hughes this week for about $35 billion in cash and stock.
11/20/14 - 04:15 PM EST
Cramer says Agios Pharmaceuticals is unique and different and yesterday its experimental cancer drug delivered some strong results in patients with advanced leukemia.
11/19/14 - 12:31 PM EST
- Tickers in this article:
Coverage decisions are still likely to slowly build over time but it is a clear positive that we are seeing the early adopters start to reimburse for Foundation's cancer tests.
11/19/14 - 11:17 AM EST
Healthcare investors are watching closely the race between Clovis and AstraZeneca to develop competing, targeted lung cancer drugs.
11/19/14 - 09:38 AM EST
The experimental drug from Agios, designed to attack the "metabolism" of cancer cells, has demonstrated early but strong clinical responses in a study involving patients with advanced leukemia.
11/18/14 - 06:02 PM EST
Inflation picked up in October due to higher prices that U.S. companies received for new model cars, beef, pork, pharmaceuticals and electric power.
11/18/14 - 03:50 PM EST
Goldman Sachs cemented its status as the number one financial adviser for global mergers & acquisitions volume, at $873 billion year-to-date, according to Thomson Reuters.
11/18/14 - 01:57 PM EST
TheStreet's Jim Cramer says Zoetis' $500 million buyback is a defense tactic to prevent a takeover, while shares of GoPro are headed higher despite its secondary offering.
11/18/14 - 10:55 AM EST
Shares of Teva remain relatively inexpensive despite the stock's sharp move higher this year, said Andrew Ver Planck, portfolio manager for the MainStay International Opportunities Fund.
11/17/14 - 05:36 PM EST
No big moves on Wall Street but the S&P 500 still managed to close at a record high Monday.
11/17/14 - 04:55 PM EST
Actavis is finalizing a $66 billion deal to buy Botox-maker Allergan for a combination of cash and stock.
11/17/14 - 01:40 PM EST
Shares of Teva Pharmaceuticals remain relatively inexpensive despite the stock's sharp move higher this year, said Andrew Ver Planck, portfolio manager for the MainStay International Opportunities Fund.
11/17/14 - 01:26 PM EST